Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Dow
McKinsey
Merck

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Lysergic Acid Diethylamide


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Lysergic Acid Diethylamide?

Lysergic Acid Diethylamide is an investigational drug.

There have been 20 clinical trials for Lysergic Acid Diethylamide. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2019.

The most common disease conditions in clinical trials are Anxiety Disorders, Headache, and Cluster Headache. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Matthias Liechti, and Psychiatric University Hospital, Zurich.

There are three hundred and forty-eight US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Lysergic Acid Diethylamide
TitleSponsorPhase
Effects of SERT Inhibition on the Subjective Response to LSD in Healthy SubjectsUniversity Hospital, Basel, SwitzerlandPhase 1
Effects of LSD on Neuroplasticity in Healthy SubjectsUniversity of FribourgPhase 1
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy SubjectsUniversity Hospital, Basel, SwitzerlandPhase 1

See all Lysergic Acid Diethylamide clinical trials

Clinical Trial Summary for Lysergic Acid Diethylamide

Top disease conditions for Lysergic Acid Diethylamide
Top clinical trial sponsors for Lysergic Acid Diethylamide

See all Lysergic Acid Diethylamide clinical trials

US Patents for Lysergic Acid Diethylamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lysergic Acid Diethylamide ⤷  Try it Free Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA) ⤷  Try it Free
Lysergic Acid Diethylamide ⤷  Try it Free Wearable apparatus for detecting a target substance in a liquid Undercover Colors, Inc. (Raleigh, NC) ⤷  Try it Free
Lysergic Acid Diethylamide ⤷  Try it Free Pharmaceutical compositions for treating or preventing pain LOCL PHARMA, INC. (Las Vegas, NV) ⤷  Try it Free
Lysergic Acid Diethylamide ⤷  Try it Free Methods and apparatus for detecting compounds in liquids Undercover Colors, Inc. (Raleigh, NC) ⤷  Try it Free
Lysergic Acid Diethylamide ⤷  Try it Free Methods of improving behavioral therapies Emory University (Atlanta, GA) ⤷  Try it Free
Lysergic Acid Diethylamide ⤷  Try it Free Pharmaceutical compositions LOCAL PHARMA, INC. (Las Vegas, NV) ⤷  Try it Free
Lysergic Acid Diethylamide ⤷  Try it Free Method and device for vaporization and inhalation of isolated substances Syqe Medical Ltd. (Tel-Aviv, IL) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Lysergic Acid Diethylamide

Drugname Country Document Number Estimated Expiration Related US Patent
Lysergic Acid Diethylamide Australia AU2003247876 2022-07-05 ⤷  Try it Free
Lysergic Acid Diethylamide Canada CA2491572 2022-07-05 ⤷  Try it Free
Lysergic Acid Diethylamide Canada CA2569958 2022-07-05 ⤷  Try it Free
Lysergic Acid Diethylamide Canada CA2916869 2022-07-05 ⤷  Try it Free
Lysergic Acid Diethylamide Cyprus CY1119831 2022-07-05 ⤷  Try it Free
Lysergic Acid Diethylamide Denmark DK1765292 2022-07-05 ⤷  Try it Free
Lysergic Acid Diethylamide European Patent Office EP1594467 2022-07-05 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.